ABiC Downloads

MIGS WHITEPAPER

Migs and Meds: Is there a Better Option?
Download Whitepaper

ABiC WHITEPAPER

The Minimally Invasive Glaucoma Surgery that Keeps its Promise
Download Whitepaper

ABiC CASE SERIES

Interim 24-Month Data
Mark J. Gallardo, MD (USA)

Retrospective analysis, single-center, non-randomized study to demonstrate the efficacy and safety of ABiC in reducing IOP and glaucoma medication dependence in patients with uncontrolled, mild to moderate primary open angle glaucoma (POAG). At 24 months postoperatively there was a 39.06% reduction in mean IOP, as compared to baseline, and a 70.15% reduction in the mean number of medications.
(Interim data only. Not published.)

ABiC CASE SERIES

Interim 18-Month Data
Mahmoud A. Khaimi, MD (USA)

Retrospective analysis, single-center, non-randomized study involving 59 patients with mild to moderate primary open angle glaucoma (POAG). At 18 months postoperatively there was a 23.6% reduction in mean IOP, as compared to baseline, combined with a 64.8% reduction in the mean number of medications.
(Interim data only. Not published.)

ABiC CASE SERIES

12-Month Data
Professor Norbert Koerber FEBO (Germany)

Twenty-three patients (23 eyes) were enrolled in the study. Mean IOP reduced from 18.8 ± 5.63 mm Hg preoperatively to 14.73 ± 2.97 (n=11) at 12 months postoperatively. Follow-up data beyond 6 months postoperative was only available for half of the total number of patients who underwent ABiC. The mean number of medications was reduced from 1.69 preoperatively to 0.21 at the last follow-up visit.

(Koerber N. Kanaloplastk ab interno – eine minimalinvasive Alternative. Klin Monatsbl Augenheikld. December 2017.)

CATARACT AND REFRACRIVE SURGERY TODAY (CRST)

A New MIGS Procedure for Comprehensive Glaucoma Treatment
Download Advertorial

CATARACT AND REFRACRIVE SURGERY TODAY (CRST)

ABiC… Easy as 1,2,3
Download Advertorial

CATARACT AND REFRACRIVE SURGERY TODAY (CRST)

A New MIGS on the Block
Download Supplement

iTrack Downloads